William Valle - 12 Jun 2025 Form 4 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Role: Director
Signature: /s/ Mary Szela, Attorney-in-Fact
Issuer symbol: TLSI
Transactions as of: 12 Jun 2025
Net transactions value: $0
Form type: 4
Filing time: 27 Jun 2025, 16:16:14 UTC
Previous filing: 31 Jan 2025
Next filing: 23 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Valle William	Director	6272 W. 91ST AVENUE, WESTMINSTER	/s/ Mary Szela, Attorney-in-Fact	27 Jun 2025	0002018493

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TLSI	Director Stock Option (right to buy)	Award	$0	+15,000	+36%	$0.000000	56,250	12 Jun 2025	Common Stock	15,000	$5.50	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to the option shall fully vest on the one-year anniversary of the grant date of June 12, 2025, provided that the shares subject to the option will in any case be fully vested on the date of the Issuer's next annual stockholder meeting, subject to the Reporting Person's continued service with the Issuer.